CB 2009 companion diagnostic - CORTIBON
Latest Information Update: 28 May 2024
Price :
$50 *
At a glance
- Originator HolsboerMaschmeyer NeuroChemie
- Class Diagnostic agents
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Anxiety disorders; Depressive disorders; Sleep disorders
Most Recent Events
- 28 May 2024 No recent reports of development identified for preclinical development in Anxiety-disorders(Diagnosis) in Germany
- 28 May 2024 No recent reports of development identified for preclinical development in Depressive disorders(Diagnosis) in Germany
- 28 May 2024 No recent reports of development identified for preclinical development in Sleep-disorders(Diagnosis) in Germany